Literature DB >> 11867346

Inward rectifier K(+) current in human bronchial smooth muscle cells: inhibition with antisense oligonucleotides targeted to Kir2.1 mRNA.

Hitoshi Oonuma1, Kuniaki Iwasawa, Haruko Iida, Taiji Nagata, Hiroyuki Imuta, Yutaka Morita, Kazuhiko Yamamoto, Ryozo Nagai, Masao Omata, Toshiaki Nakajima.   

Abstract

Inward rectifier K(+) (Kir) channels play an important role in forming membrane potential and then modulating muscle tone in certain types of smooth muscles. In cultured human bronchial smooth muscle cells (hBSMCs), Kir current was identified using whole-cell voltage clamp techniques and explored by using RT-PCR analysis of mRNA, Western blotting, and antisense oligonucleotide methods to block the synthesis of Kir channel protein. The K(+) current with strong inward rectification and high K(+) ion selectivity was observed. The current was unaffected by 4-aminopyridine, glibenclamide, and charybdotoxin, and hardly inhibited by tetraethylammonium, but was potently inhibited by extracellular Ba(2+). The IC(50) value of external Ba(2+) was approximately 1.3 microm. RT-PCR analysis of mRNA showed transcripts for Kir2.1, but not Kir1.1, Kir2.2, or Kir2.3. Treatment of cells with antisense oligonucleotides targeted to Kir2.1 resulted in a decrease in the current density of the Kir current and Kir protein expression, as compared with the mismatch-treated cells, whereas the current density of 4-AP-sensitive K(+) currents (K(V)) remained unaffected. The application of Ba(2+) markedly depolarized the membrane. These results demonstrate that Kir channel is present in human bronchial smooth muscle cells, and the Kir2.1 gene encodes the Kir channel protein in these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867346     DOI: 10.1165/ajrcmb.26.3.4542

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

1.  Molecular and pharmacological characteristics of transient voltage-dependent K+ currents in cultured human pulmonary arterial smooth muscle cells.

Authors:  Haruko Iida; Taisuke Jo; Kuniaki Iwasawa; Toshihiro Morita; Hisako Hikiji; Tsuyoshi Takato; Teruhiko Toyo-Oka; Ryozo Nagai; Toshiaki Nakajima
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol.

Authors:  Victor G Romanenko; George H Rothblat; Irena Levitan
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

3.  Comparison of K+ Channel Families.

Authors:  Jaume Taura; Daniel M Kircher; Isabel Gameiro-Ros; Paul A Slesinger
Journal:  Handb Exp Pharmacol       Date:  2021

4.  Relaxant effect of Ent-7α-hydroxytrachyloban-18-oic acid, a trachylobane diterpene from Xylopia langsdorfiana A. St-Hil. & Tul., on tracheal smooth muscle.

Authors:  Italo R R Martins; Rosimeire F Dos Santos; Ana C de C Correia; Gislaine A de Oliveira; Cibério L Macêdo; Fabio de S Monteiro; Paula F Dos Santos; Fabiana de A Cavalcante; Josean F Tavares; Bagnólia A da Silva
Journal:  J Smooth Muscle Res       Date:  2013

5.  Functional expression of inward rectifier potassium channels in cultured human pulmonary smooth muscle cells: evidence for a major role of Kir2.4 subunits.

Authors:  Brian P Tennant; Yi Cui; Andrew Tinker; Lucie H Clapp
Journal:  J Membr Biol       Date:  2007-03-08       Impact factor: 1.843

6.  Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.

Authors:  Dana B Hancock; María Soler Artigas; Sina A Gharib; Amanda Henry; Ani Manichaikul; Adaikalavan Ramasamy; Daan W Loth; Medea Imboden; Beate Koch; Wendy L McArdle; Albert V Smith; Joanna Smolonska; Akshay Sood; Wenbo Tang; Jemma B Wilk; Guangju Zhai; Jing Hua Zhao; Hugues Aschard; Kristin M Burkart; Ivan Curjuric; Mark Eijgelsheim; Paul Elliott; Xiangjun Gu; Tamara B Harris; Christer Janson; Georg Homuth; Pirro G Hysi; Jason Z Liu; Laura R Loehr; Kurt Lohman; Ruth J F Loos; Alisa K Manning; Kristin D Marciante; Ma'en Obeidat; Dirkje S Postma; Melinda C Aldrich; Guy G Brusselle; Ting-hsu Chen; Gudny Eiriksdottir; Nora Franceschini; Joachim Heinrich; Jerome I Rotter; Cisca Wijmenga; O Dale Williams; Amy R Bentley; Albert Hofman; Cathy C Laurie; Thomas Lumley; Alanna C Morrison; Bonnie R Joubert; Fernando Rivadeneira; David J Couper; Stephen B Kritchevsky; Yongmei Liu; Matthias Wjst; Louise V Wain; Judith M Vonk; André G Uitterlinden; Thierry Rochat; Stephen S Rich; Bruce M Psaty; George T O'Connor; Kari E North; Daniel B Mirel; Bernd Meibohm; Lenore J Launer; Kay-Tee Khaw; Anna-Liisa Hartikainen; Christopher J Hammond; Sven Gläser; Jonathan Marchini; Peter Kraft; Nicholas J Wareham; Henry Völzke; Bruno H C Stricker; Timothy D Spector; Nicole M Probst-Hensch; Deborah Jarvis; Marjo-Riitta Jarvelin; Susan R Heckbert; Vilmundur Gudnason; H Marike Boezen; R Graham Barr; Patricia A Cassano; David P Strachan; Myriam Fornage; Ian P Hall; Josée Dupuis; Martin D Tobin; Stephanie J London
Journal:  PLoS Genet       Date:  2012-12-20       Impact factor: 5.917

7.  A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.

Authors:  M Hardin; M H Cho; M-L McDonald; E Wan; D A Lomas; H O Coxson; W MacNee; J Vestbo; J C Yates; A Agusti; P M A Calverley; B Celli; C Crim; S Rennard; E Wouters; P Bakke; S P Bhatt; V Kim; J Ramsdell; E A Regan; B J Make; J E Hokanson; J D Crapo; T H Beaty; C P Hersh
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.